Aplastic anemia: history and recent developments in diagnosis and treatment
Open Access
- 4 February 2024
- journal article
- editorial
- Published by Springer Nature in International Journal of Hematology
- Vol. 119 (3) , 217-219
Abstract
Acquired aplastic anemia is an immune-mediated disease that targets hematopoietic stem cells, which is diagnosed by findings of peripheral blood pancytopenia and hypocellular bone marrow. Although the diagnostic definition is simple, differential diagnosis from other overlapping hematopoietic disorders such as hypoplastic myelodysplastic syndrome and inherited bone marrow failure syndrome is not easy. Immune suppressive therapy and allogeneic hematopoietic stem cell transplantation are important treatment approaches for aplastic anemia, and both have advanced in recent years. This issue of Progress in Hematology covers four topics related to aplastic anemia: (1) laboratory markers to identify immune pathophysiology and their role on differential diagnosis and prognosis, (2) the path to combination therapy with horse anti-thymocyte globulin, cyclosporine A, and eltrombopag, (3) more than 60 years of history and recent trends in allogeneic HSCT, and (4) genetic testing for differential diagnosis from IBMFS and novel approaches to transplantation for children including fludarabine/melphalan-based conditioning.Keywords
This publication has 22 references indexed in Scilit:
- Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemiaBlood, 2011
- Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemiaBlood, 2011
- Epidemiology of aplastic anemia: a prospective multicenter studyHaematologica, 2008
- Current concepts in the pathophysiology and treatment of aplastic anemiaBlood, 2006
- Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemiaBlood, 2006
- Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide exposure. Aplastic Anemia Study Group.American Journal of Public Health, 1997
- Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without CyclosporineNew England Journal of Medicine, 1991
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Antithymocyte Globulin Treatment in Patients with Aplastic AnemiaNew England Journal of Medicine, 1983
- APLASTIC ANAEMIA TREATED BY MARROW TRANSPLANTATIONThe Lancet, 1972